NOTE AMENDMENT AND EXCHANGE AGREEMENTNote Amendment and Exchange Agreement • January 27th, 2016 • BeiGene, Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 27th, 2016 Company Industry JurisdictionTHIS NOTE AMENDMENT AND EXCHANGE AGREEMENT (this “Agreement”) is executed on January 26, 2016 (the “Effective Date”), by and between Merck Sharp & Dohme Research GMBH, an affiliate of Merck Sharp & Dohme Corp. (“Lender”) and BeiGene, Ltd., a Cayman Islands exempted company (“Company” and, together with Lender, the “Parties”).